2015 American Transplant Congress » Concurrent Session: Heart De-"Mystification": Rejection and Antibodies of All Types

Date: Monday, May 4, 2015

Time: 2:15pm-3:45pm

Location: Room 118-C

Session Type: Concurrent Session

Meeting: 2015 American Transplant Congress

2:15pm-2:27pm: Elevated ST2 Levels Are Associated With Increased Risk of Antibody Mediated Rejection in Heart Transplant Recipients

A. Grupper,¹ S. Kushwaha,¹ O. Abou Ezzeddine,¹ J. Geske,² W. Kremers,² B. Edwards,¹ N. Pereira.¹

2:27pm-2:39pm: Natural History of Anti- Human Leukocyte Antigen Antibodies After Hear Transplant

J. Kobashigawa, M. Kittleson, F. Liou, S. Siddiqui, R. Shiozaki, L. Piponniau, D. Geft, M. Hamilton, L. Czer, N. Reinsmoen, J. Patel.

2:39pm-2:51pm: Risk of HLA Antibody Sensitization in Pediatric Heart Failure Patients Pre/Post Berlin VAD Procedure and Pre/Post Heart Transplantation

R. Kerman, P. Jindra, A. Jeewa, S. Burki, C. Fraser, I. Adachi.

2:51pm-3:03pm: Donor-Derived Cell-Free DNA Is Stable in Non-Rejecting Heart Transplant Recipients in the CARGO II Multicenter Trial

D. Hiller,¹ M. Grskovic,¹ J. Beausang,¹ R. Sit,¹ B. Christie,¹ J. Elechko,¹ R. Woodward,¹ J. Yee,¹ H. Eisen.²

3:03pm-3:15pm: Molecular Correlates of Endothelial mTOR Activation in Heart Transplants Recipients

M. Racape, A. Loupy, J. Reeve, J. Venner, R. Guillemain, L. Hidalgo, C. Lefaucheur, X. Jouven, P. Bruneval, P. Halloran, J. Duong.

3:15pm-3:27pm: Outcome of Bortezomib/Plasmapheresis for the Sensitized Patient Awaiting Heart Transplant

J. Patel, N. Reinsmoen, M. Kittleson, D. Dilibero, F. Liou, D. Chang, M. Hamilton, L. Czer, F. Esmailian, J. Kobashigawa.

3:27pm-3:39pm: The Use of Eculizumab to Treat the Highly Sensitized Patient Awaiting Heart Transplant

J. Patel, D. Dilibero, M. Kittleson, S. Sana, F. Liou, D. Chang, A. Hage, L. Czer, A. Trento, N. Reinsmoen, J. Kobashigawa.

« View all sessions from the 2015 American Transplant Congress